NCT07528144

Brief Summary

The goal of this clinical trial is to learn whether an exoskeleton-supported radiation protection system can reduce radiation exposure and musculoskeletal strain in vascular surgeons during endovascular aortic repair procedures, compared with standard lead aprons. Researchers will compare procedures performed with exoskeleton-supported protection and procedures performed with standard lead aprons. Radiation exposure, physical strain, fatigue, and discomfort will be assessed during and after procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Nov 2025Jun 2027

Study Start

First participant enrolled

November 3, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2027

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

April 7, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

EVARBEVARIBD-EVARExoskeletonLead ApronOccupational SafetyIonizing RadiationVascular SurgeonErgonomics

Outcome Measures

Primary Outcomes (2)

  • Operator musculoskeletal strain assessed during endovascular aortic repair procedures using shoulder load sensors.

    Operator weight distribution and physical load assessed during endovascular aortic repair procedures using foot-mounted load sensors.

    During each procedure

  • Operator radiation exposure

    Operator radiation exposure measured during endovascular aortic repair procedures using real-time personal dosimetry.

    During each procedure

Study Arms (2)

Exoskeleton-Supported Protection System

EXPERIMENTAL

Endovascular aortic repair procedures performed with an exoskeleton-supported radiation protection system with visor.

Device: Exoskeleton-supported radiation protection system

Standard Lead Apron

ACTIVE COMPARATOR

Endovascular aortic repair procedures performed with standard lead apron radiation protection.

Device: Standard lead apron

Interventions

A standard lead apron used by the operator during endovascular aortic repair procedures.

Standard Lead Apron

An exoskeleton-supported radiation protection system with visor used by the operator during endovascular aortic repair procedures.

Exoskeleton-Supported Protection System

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 35 years or older
  • written informed consent obtained
  • vascular surgeon with substantial experience in endovascular procedures
  • active participation in endovascular aortic repair procedures as a primary operator or assistant
  • high procedural volume in endovascular interventions

You may not qualify if:

  • refusal or inability to provide informed consent
  • medical contraindications to the use of standard lead aprons or the exoskeleton-supported radiation protection system
  • health conditions preventing safe participation in study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinical Hospital No. 2, Pomeranian Medical University

Szczecin, West Pomeranian Voivodeship, 70-111, Poland

RECRUITING

Central Study Contacts

Paweł Rynio, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 14, 2026

Study Start

November 3, 2025

Primary Completion (Estimated)

June 17, 2027

Study Completion (Estimated)

June 17, 2027

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because of the small sample size and the risk of participant identification.

Locations